1. Home
  2. Live Updates
  3. Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $22.83 Con

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $22.83 Con

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $22.83 Consensus Target Price from Analysts

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $22.83 Consensus Target Price from Analysts

theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , Kristina Burow , William Blair , Stifel Nicolaus , Nasdaq , Neumora Therapeutics Inc , Jpmorgan Chase Co , Arch Venture Partners Xii Llc , Wellcome , Neumora Therapeutics Company Profile , Royal Bank , Securities Exchange Commission , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Director Kristina Burow , Exchange Commission , Free Report , Get Free , Neumora Therapeutics Daily ,